GFAP elevation may signal increased risk of progressive regional atrophy, cognitive decline
Scoping review implicates temperature extremes, air pollutants, expanding infectious disease risk
Investigative highlights include hormone therapies, biomarkers and early lifestyle interventions
Will enable sharper focus on new diagnostic tools for elusive neurodegenerative disease
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
New grant-funded investigation illustrates impact and reach of Cleveland Clinic Brain Study
Essentials of the landmark longitudinal study from two lead researchers
How the new longitudinal investigation could become the Framingham Heart Study of brain health
First-of-kind study aims to enable prevention of brain disorders before symptoms appear
An update on biomarkers and various therapies in development
Cohort study characterizes symptomatology by Alzheimer’s and Lewy body pathology